Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:5:45-8.
doi: 10.1007/8904_2011_92. Epub 2011 Dec 21.

Adenine phosphoribosyltransferase deficiency: an underdiagnosed cause of lithiasis and renal failure

Affiliations

Adenine phosphoribosyltransferase deficiency: an underdiagnosed cause of lithiasis and renal failure

Giuseppina Marra et al. JIMD Rep. 2012.

Abstract

We describe an infant affected by adenine phosphoribosyltransferase (APRT) deficiency diagnosed at 18 months of age with a de novo mutation that has not been previously reported. APRT deficiency is a rare defect of uric acid catabolism that leads to the accumulation of 2,8 dihydroxyadenine (2,8-DHA), a highly insoluble substance excreted by the kidneys that may precipitate in urine and form stones. The child suffered from renal colic due to a stone found in the peno-scrotal junction of the bulbar urethra. Stone spectrophotometric analysis allowed us to diagnose the disease and start kidney-saving therapy in order to avoid irreversible chronic kidney damage. APRT deficiency should always be considered in the differential diagnosis of pediatric urolithiasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Ultrasound images before therapy at 3 (a) and 9 months of age (b), and after 1 year of therapy (c)
Fig. 2
Fig. 2
Spectrophotometry of the surgically extracted stone

References

    1. Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J, Lipkowitz G. Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis. 2001;37(5):E37. doi: 10.1016/S0272-6386(05)90001-2. - DOI - PubMed
    1. Bollée G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceballos-Picot I. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol. 2010;21(4):679–688. doi: 10.1681/ASN.2009080808. - DOI - PMC - PubMed
    1. Bouzidi H, Lacour B, Daudon M. 2,8-Dihydroxyadenine nephrolithiasis: from diagnosis to therapy. Ann Biol Clin (Paris) 2007;65(6):585–592. - PubMed
    1. Ceballos-Picot I, Perignon JL, Hamet M, Daudon M, Kamoun P. 2,8-Dihydroxyadenine urolithiasis, an underdiagnosed disease. Lancet. 1992;339:1050–1051. doi: 10.1016/0140-6736(92)90569-O. - DOI - PubMed
    1. Edvardsson V, Palsson R, Olafsson I, Hijaltadottir G, Laxdal T. Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis. 2001;38(3):473–480. doi: 10.1053/ajkd.2001.26826. - DOI - PubMed

LinkOut - more resources